Revolutionizing drug delivery

Our proprietary microchip-based implant can store and release precise doses of drugs at scheduled intervals for up to 16 years

Learn More

Pioneering the next generation of
drug delivery and biosensing

In 2012, we received grants from the Bill & Melinda Gates Foundation to develop a microchip-based contraceptive implant that provides 16 years of reversible birth control for women in developing countries who have limited access to routine medical care and modern contraceptive options.

Learn More


Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery


Our proprietary microchip-based implant can enhance the utility and compliance of established agents requiring frequent, long-term dosing


Physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient

Latest News

February 5, 2015
Microchips Biotech, Inc. CEO Cheryl R. Blanchard, Ph.D., Elected to National Academy of Engineering
View Article

December 15, 2014
Microchips Biotech, Inc. Completes Development and Clinical Demonstration of Proprietary Drug Delivery Platform and Advances Commercialization Efforts in Diabetes, Contraception and Osteoporosis
View Article